APA (7th ed.) Citation

T, L., P, G., L, N., C, W., SK, K., I, H., . . . R, A. (2026). Description of the Tranquillo Phase 3 Clinical Trial Designs/Study Protocols to Assess Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo. Dermatology and therapy, 16(7), 3709. https://doi.org/10.1007/s13555-026-01724-y

Chicago Style (17th ed.) Citation

T, Lukic, et al. "Description of the Tranquillo Phase 3 Clinical Trial Designs/Study Protocols to Assess Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo." Dermatology and Therapy 16, no. 7 (2026): 3709. https://doi.org/10.1007/s13555-026-01724-y.

MLA (9th ed.) Citation

T, Lukic, et al. "Description of the Tranquillo Phase 3 Clinical Trial Designs/Study Protocols to Assess Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo." Dermatology and Therapy, vol. 16, no. 7, 2026, p. 3709, https://doi.org/10.1007/s13555-026-01724-y.